You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 16, 2025

Details for Patent: 8,227,490


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,227,490
Title:Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
Abstract: Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis. ##STR00001##
Inventor(s): Bohn; Manfred (Hofheim, DE), Kraemer; Karl Theodor (Langen, DE), Markus; Astrid (Liederbach, DE)
Assignee: Medicis Pharmaceutical Corporation (Scottsdale, AZ)
Application Number:13/177,710
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,227,490

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This analysis will delve into the specifics of United States Patent 8,227,490, exploring its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 8,227,490, hereafter referred to as the '490 patent, is a patent granted by the U.S. Patent and Trademark Office (USPTO). To analyze this patent, one must first identify its key components:

Title and Abstract

The title and abstract provide a preliminary understanding of the invention. While the specific title and abstract of the '490 patent are not provided here, these sections typically outline the main subject matter and the innovative aspects of the invention.

Claims

The claims section is the most critical part of a patent, as it defines the scope of the invention and what is protected by the patent. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to one or more of the independent claims.

Claim Analysis

Independent Claims

Independent claims in the '490 patent would outline the broadest aspects of the invention. These claims are essential because they define the boundaries of what is considered novel and non-obvious.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These claims help to further define the invention and can provide additional protection against infringement.

Scope of the Patent

The scope of a patent is determined by the language of the claims. Here are some key aspects to consider:

Claim Language

The language used in the claims is crucial. It must be clear and specific to avoid ambiguity. Metrics such as independent claim length and independent claim count can be used to measure patent scope, as discussed in research on patent quality[3].

Patent Scope Metrics

  • Independent Claim Length: Longer independent claims often indicate a narrower scope, as they include more specific details.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, as it covers more aspects of the invention.

Patent Landscape

Related Patents and Applications

To understand the '490 patent's place in the broader patent landscape, it is essential to look at related patents and applications. Tools like the USPTO's Global Dossier can help identify the patent family and related applications filed at participating IP Offices[4].

Prior Art and Citations

Analyzing prior art and citations can provide insights into the novelty and non-obviousness of the '490 patent. Forward citations, which are citations to the '490 patent by later patents, can indicate its impact and relevance in the field.

Obviousness-Type Double Patenting (ODP)

ODP is a critical consideration in patent law, particularly when dealing with multiple patents from the same inventor or assignee. The Federal Circuit has ruled that ODP analyses must be performed on patents that have overlapping subject matter, even if a terminal disclaimer is filed to overcome ODP rejections[1].

Terminal Disclaimers

Terminal disclaimers are often used to overcome ODP rejections. However, as seen in the case of In re Cellect LLC, terminal disclaimers do not extend the patent term beyond the specified date of the disclaimer, even if a Patent Term Adjustment (PTA) is granted[1].

Inventorship and Ownership

Correctly determining inventorship is vital for the validity and enforceability of a patent. The '490 patent must list the "true and only" inventors, as incorrect or incomplete identification can lead to the patent being declared invalid or unenforceable[5].

Public Search and Access

The USPTO provides various tools for searching and accessing patent information. The Public Search Facility in Alexandria, VA, and online resources like the USPTO's patent search database, allow users to find and review the '490 patent and related documents[4].

Enforcement and Litigation

Understanding the scope and claims of the '490 patent is also crucial for enforcement and litigation purposes. A clear and well-defined scope helps in identifying potential infringers and defending against infringement claims.

Key Takeaways

  • Claims Analysis: The claims section is the heart of the patent, defining what is protected.
  • Scope Metrics: Independent claim length and count can help measure the patent's scope.
  • ODP and Terminal Disclaimers: These are critical in ensuring that the patent does not overlap with other patents from the same inventor or assignee.
  • Inventorship: Correct identification of inventors is essential for the patent's validity.
  • Public Access: Utilize USPTO resources to search and access patent information.

FAQs

  1. What is the significance of independent claims in a patent? Independent claims define the broadest aspects of the invention and are crucial for determining the scope of the patent.

  2. How does the USPTO handle obviousness-type double patenting (ODP)? The USPTO requires an ODP analysis to be performed on patents that have overlapping subject matter, even if a terminal disclaimer is filed.

  3. What are the consequences of incorrect inventorship in a patent application? Incorrect inventorship can lead to the patent being declared invalid or unenforceable, especially if there is deceptive intent.

  4. How can one measure the scope of a patent? Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent.

  5. What resources are available for searching and accessing patent information? The USPTO provides the Public Search Facility and online databases for searching and accessing patent information.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USA.gov.
  3. Patent Claims and Patent Scope, SSRN, September 29, 2016.
  4. Search for patents - USPTO, USPTO, October 18, 2018.
  5. Determining Inventorship for US Patent Applications, Oregon State University.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,227,490

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 8,227,490

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany196 39 818Sep 27, 1996

International Family Members for US Patent 8,227,490

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 008860 ⤷  Try for Free
Australia 4774697 ⤷  Try for Free
Australia 716208 ⤷  Try for Free
Austria 209891 ⤷  Try for Free
Bulgaria 103260 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.